Read + Share
Seymour JF, Kipps TJ, Eichhorst BF, D'Rozario J, et al. Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after
fixed-duration venetoclax-rituximab. Blood 2022;140:839-850.
PMID: 35605176
|
 |
|
Seymour JF, Kipps TJ, Eichhorst BF, D'Rozario J, et al. Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after
fixed-duration venetoclax-rituximab. Blood 2022;140:839-850.
PMID: 35605176
|
|
|
|